MAGEA3 and melanoma: A combination of cancer testis antigens, MAGE-C2, MAGE-A3 and NY-ESO-1, and tumor-associated antigens, gp100 and tyrosinase, was chosen as they are known to be widely expressed on melanoma and are able to induce cytotoxic T cells that can lyse tumor cells.